Active Pharmaceutical Ingredients Market
Active Pharmaceutical Ingredients Market by Business Mode (Captive API, Merchant API), by Synthesis Type (Synthetic, Biotech), by Type Of Drug (Generic, Branded), by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)
The global Active Pharmaceutical Ingredients market was valued at USD 189.51 Billion in 2020 and is projected to reach USD 308.96 Billion by 2028, growing at a CAGR of 6.30% from 2021 to 2028.
|Historical Data (Actual Data)||2016-2020|
|Base Year Data||2020|
|Current Year Date||2021|
|Projected year data||2021-2026|
|Annual Market Size (2028)||308.96 Billion|
|Annual Market Size (2021)|
|CAGR (2021 - 2028)||6.30%|
Definition and Overview
Active Pharmaceutical Ingredients are responsible for the pharmaceutical effect of formulated medicines. Few drugs, like combination therapies, have various active ingredients to treat different symptoms or act in different ways. The high quality drugs that uses APIs for treating various diseases include oncology, cardiology, CNS and neurology, orthopaedic, pulmonology, gastroenterology, nephrology, ophthalmology, and endocrinology. APIs are helpful in creating sustainable healthcare system by introducing more innovative products.
The global Active Pharmaceutical Ingredients market report provides exhaustive analysis on segments, regions/countries, companies, and such several strategic marketing tools such as Porter’s Five Forces Analysis, Pricing Analysis, SWOT Analysis, PESTLE Analysis, Player Positioning Analysis, Downstream Buyers, List of distributors, and Value Chain Analysis among others. The report covers market size and estimations for each segment/region/country for the years 2016–2028. It provides a detailed study on various product types and their applications in different industry verticals at the global/regional/country level. Moreover, the report includes a thorough analysis on competitive landscape comprising of extensive company profiles based on various parameters such as company overview, market revenue, business, product portfolio, and marketing strategies among others.
COVID-19 Impact Analysis
Outbreak of COVID-19 in 2020 compelled governments across the world to take severe actions like border seals, lockdown, and implementing strict social distancing measures, in order to restrict swift spread of COVID-19. However, these actions had a drastic impact on the global economy, as the companies across the globe were forced to either close or partially closed their operations, leading to supply chain disruptions and impairing of various industries. Moreover, in 2021 several key markets such as U.S., India, and Brazil among other witnessed second wave of COVID-19 that further disrupted the market. However, it is expected that reopening of trade activities, the market will witness steady growth in demand in the coming years. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends for all the regions and countries.
The report provides a completely separate chapter for COVID-19 Impact Analysis.
This chapter includes:
- Impact Assessment of COVID-19 Pandemic
- Pre & Post COVID-19 Market Size
- Qualitative analysis on the short term & long-term impact of COVID-19 on the market
- The analysis provides foremost strategies adopted by competitors to minimize the impact of the pandemic on their business activities and scope for future developments.
Global Active Pharmaceutical Ingredients Market Report Scope
|Market Size Provided for Years||2016-2028|
|Market Size Provided In Terms Of||Revenue & Volume|
|Segments Covered||Business Mode, Synthesis Type, Type Of Drug|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Countries Covered||The U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, South East Asia, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Companies Covered||Cipla, Inc., Novartis International AG, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Mylan N.V., AstraZeneca, Dr. Reddy’s Laboratories Ltd., AbbVie Inc.|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis|
The report delivers an acute breakdown of the market based on various segments such as Business Mode, Synthesis Type and region. This study comprises the market size in terms of revenue for each segment at the global/regional/country level along with a detailed analysis of growth prospects, challenges, and opportunities.
On the basis of Business Mode, the market is divided into Captive API, Merchant API. Captive API is expected to dominate the market and is projected to grow at a noteworthy CAGR within the forecast period.
Based on Synthesis Type, the market is divided into Synthetic, Biotech. Biotech attributed to the highest market share and is expected to grow at a significant CAGR from 2021 to 2028.
Global Active Pharmaceutical Ingredients Market: Business Mode Segment Analysis
- Captive API
- Merchant API
Global Active Pharmaceutical Ingredients Market: Synthesis Type Segment Analysis
Global Active Pharmaceutical Ingredients Market: Type Of Drug Segment Analysis
Global Active Pharmaceutical Ingredients Market: Segment Analysis
Regional Analysis: Preview
Geographically, the global Active Pharmaceutical Ingredients market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. The report further segments the regional study into key country-level markets from each region. The regional analysis section provides extensive analysis on various factors impacting market growth such as economies, industry competition, technological advancements, import-export ratio, and raw material availability among others. Moreover, the same section will provide your detailed qualitative as well as quantitative analysis for each region country comprising of market size and estimations for each region/country. Some of the prominent country-level markets are U.S., China, Germany, France, India, and Japan. North America is anticipated to dominate the global market during upcoming years.
Market Size, 2021 (USD Billion)
Global Active Pharmaceutical Ingredients Market: Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of MEA
Major players in the global Active Pharmaceutical Ingredients market are Cipla, Inc., Novartis International AG, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Mylan N.V., AstraZeneca, Dr. Reddy’s Laboratories Ltd., AbbVie Inc.. The global Active Pharmaceutical Ingredients market report analyzes competitive scenario in detail that includes extensive information on all key players based on business overview, product portfolio, marketing strategies, recent developments, financial performance, and geographical presence among others. In addition to that, the report also covers company market share for the year 2020 along with in depth strategic developments.
Global Active Pharmaceutical Ingredients Market: Key Highlights
- The global Active Pharmaceutical Ingredients market was valued at USD 189.51 Billion in 2020.
- The global Active Pharmaceutical Ingredients Market is projected to reach USD 308.96 Billion by 2028
- is fueling the market growth
- North America held the highest share of the Active Pharmaceutical Ingredients market in 2020.
- Some of the major companies operating in the Active Pharmaceutical Ingredients market are Cipla, Inc., Novartis International AG, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Mylan N.V., AstraZeneca, Dr. Reddy’s Laboratories Ltd., AbbVie Inc..
Frequently Asked Questions
the global demand for Active Pharmaceutical Ingredients
in terms of revenue?
The global Active Pharmaceutical Ingredients valued at 189.51 Billion in 2020 and is expected to reach 308.96 Billion in 2028 growing at a CAGR of 6.30%%
are the prominent players
in the market?
The prominent players in the market are Cipla, Inc., Novartis International AG, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Mylan N.V., AstraZeneca, Dr. Reddy’s Laboratories Ltd., AbbVie Inc..
At what CAGR is the market projected to grow within the forecast period?
The market is project to grow at a CAGR of 6.30%% between 2021 and 2028.
the driving factors
fueling the growth of the market.
The driving factors of the Active Pharmaceutical Ingredients include
- The increasing incidence of chronic diseases along with growing importance of generics is anticipated to augment the growth of the active pharmaceutical ingredient (API) market during the forecast period. Furthermore, increasing uptake of biopharmaceuticals and growing focus on precision medicine is also expected to support the market growth in near future.
- The increasing technological advancements in API manufacturing coupled with growing adoption of AI-based tools for drug discovery is further likely to support the market growth in the years to come.
region accounted for the
largest share in the market?
North America was the leading regional segment of the Active Pharmaceutical Ingredients in 2020.